California State Teachers Retirement System Supernus Pharmaceuticals, Inc. Transaction History

California State Teachers Retirement System

  • $83.3 Billion
  • Q4 2024

A detailed history of California State Teachers Retirement System transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, California State Teachers Retirement System holds 51,149 shares of SUPN stock, worth $1.65 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
51,149
Previous 51,149 -0.0%
Holding current value
$1.65 Million
Previous $1.85 Million -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
SELL
$31.89 - $37.83 $15,913 - $18,877
-499 Reduced 0.97%
51,149 $1.85 Million
Q3 2024

Apr 04, 2025
BUY
$25.77 - $35.16 $12,859 - $17,544
499 Added 0.98%
51,648 $1.61 Million
Q3 2024

Nov 14, 2024
SELL
$25.77 - $35.16 $48,112 - $65,643
-1,867 Reduced 3.49%
51,648 $1.61 Million
Q2 2024

Apr 08, 2025
BUY
$25.99 - $33.85 $61,492 - $80,089
2,366 Added 4.63%
53,515 $1.43 Million
Q2 2024

Aug 14, 2024
SELL
$25.99 - $33.85 $15,542 - $20,242
-598 Reduced 1.11%
53,515 $1.43 Million
Q1 2024

May 15, 2024
SELL
$27.11 - $35.17 $70,757 - $91,793
-2,610 Reduced 4.6%
54,113 $1.85 Million
Q4 2023

Feb 13, 2024
SELL
$22.72 - $29.68 $52,028 - $67,967
-2,290 Reduced 3.88%
56,723 $1.64 Million
Q3 2023

Nov 14, 2023
SELL
$27.57 - $32.91 $142,978 - $170,671
-5,186 Reduced 8.08%
59,013 $1.63 Million
Q2 2023

Aug 21, 2023
SELL
$29.91 - $38.73 $52,222 - $67,622
-1,746 Reduced 2.65%
64,199 $1.93 Million
Q1 2023

May 09, 2023
SELL
$34.93 - $42.03 $14,251 - $17,148
-408 Reduced 0.61%
65,945 $2.39 Million
Q4 2022

Feb 14, 2023
BUY
$31.09 - $37.88 $32,333 - $39,395
1,040 Added 1.59%
66,353 $2.37 Million
Q3 2022

Nov 18, 2022
SELL
$28.79 - $35.41 $36,764 - $45,218
-1,277 Reduced 1.92%
65,313 $2.21 Million
Q2 2022

Aug 15, 2022
BUY
$25.33 - $34.25 $3,976 - $5,377
157 Added 0.24%
66,590 $1.93 Million
Q1 2022

May 16, 2022
SELL
$28.51 - $32.9 $155,037 - $178,910
-5,438 Reduced 7.57%
66,433 $2.15 Million
Q4 2021

Feb 15, 2022
BUY
$26.37 - $34.22 $53,636 - $69,603
2,034 Added 2.91%
71,871 $2.1 Million
Q3 2021

Nov 15, 2021
BUY
$23.54 - $31.39 $47,974 - $63,972
2,038 Added 3.01%
69,837 $1.86 Million
Q2 2021

Aug 16, 2021
SELL
$26.72 - $33.19 $153,987 - $191,273
-5,763 Reduced 7.83%
67,799 $2.09 Million
Q1 2021

May 18, 2021
SELL
$24.15 - $31.45 $9,128 - $11,888
-378 Reduced 0.51%
73,562 $1.93 Million
Q4 2020

Feb 16, 2021
BUY
$17.7 - $25.81 $6,849 - $9,988
387 Added 0.53%
73,940 $1.86 Million
Q2 2020

Aug 17, 2020
SELL
$17.09 - $24.89 $15,825 - $23,048
-926 Reduced 1.24%
73,553 $1.75 Million
Q1 2020

May 13, 2020
SELL
$14.45 - $24.69 $12,152 - $20,764
-841 Reduced 1.12%
74,479 $1.34 Million
Q4 2019

Feb 14, 2020
SELL
$19.93 - $29.13 $30,313 - $44,306
-1,521 Reduced 1.98%
75,320 $1.79 Million
Q3 2019

Nov 15, 2019
BUY
$25.47 - $33.37 $23,355 - $30,600
917 Added 1.21%
76,841 $2.11 Million
Q2 2019

Aug 14, 2019
BUY
$29.96 - $38.87 $28,372 - $36,809
947 Added 1.26%
75,924 $2.51 Million
Q1 2019

May 09, 2019
SELL
$32.77 - $41.99 $54,627 - $69,997
-1,667 Reduced 2.17%
74,977 $2.63 Million
Q4 2018

Feb 13, 2019
BUY
$30.84 - $49.51 $53,322 - $85,602
1,729 Added 2.31%
76,644 $2.55 Million
Q3 2018

Nov 14, 2018
SELL
$42.7 - $56.55 $1,152 - $1,526
-27 Reduced 0.04%
74,915 $3.77 Million
Q2 2018

Aug 14, 2018
BUY
$44.1 - $59.85 $60,813 - $82,533
1,379 Added 1.87%
74,942 $4.49 Million
Q1 2018

May 15, 2018
SELL
$37.15 - $46.9 $95,809 - $120,955
-2,579 Reduced 3.39%
73,563 $3.37 Million
Q4 2017

Feb 14, 2018
BUY
$36.4 - $42.6 $9,536 - $11,161
262 Added 0.35%
76,142 $3.03 Million
Q3 2017

Nov 13, 2017
BUY
$36.75 - $49.65 $2.79 Million - $3.77 Million
75,880
75,880 $3.04 Million

Others Institutions Holding SUPN

# of Institutions
303
Shares Held
60.7M
Call Options Held
22.3K
Put Options Held
6K
View Full List

About SUPERNUS PHARMACEUTICALS, INC.

SUPN Quotes by TradingView
  • Ticker SUPN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 53,495,300
  • Market Cap $1.73B
  • Description
  • Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...
More about SUPN
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email